Daniela Silvia Bobos, representing Kaleido Ideas & Logistics, presented the check for 7,000€ to Dr. César Serrano, head of the…
en_news
Published in Cell Reports Medicine, results of a VHIO-led retrospective study demonstrate the potential of a novel, CT-based deep learning-driven…
La Nineta dels Ulls Foundation has donated 5.711€ to VHIO’s Hereditary Cancer Genetics Group to continue developing the CANGUR project….
The phase 3 clinical trial KEYNOTE-689 shows that incorporating the monoclonal antibody pembrolizumab before and after surgery, alongside standard of…
As part of the Severo Ochoa Patient and Citizen Involvement Programme, the 4th Patient Day was held on 10 April,…
Results of a VHIO led study show that up to 90% of chronically hypoxic patients have an EPAS1 alteration in…
The results show the need for continuous monitoring of patients to detect and manage possible adverse effects occurring months and…
Co-authored by leading experts in oncology, a review article recently published in the Journal of Clinical Oncology (JCO)* provides an…
The American Association for Cancer Research (AACR) has officially announced this year’s class of Fellows of the AACR Academy. The…
Initial results of the COMPETE phase 3 clinical trial—the first study to compare targeted radioligand therapy with molecular targeted therapy…
